DermTopic: Atopic Dermatitis

Filter Your Results

 

News

 

Lilly to Present New Data for Olumiant® and Taltz® at EADV

Eli Lilly and Company will present Phase 2 safety and efficacy data evaluating Olumiant® (baricitinib) for the …

AD Breakthrough? Medimetriks’ MM36 Achieves Rapid Itch Rel…

Medimetriks’ PDE4 inhibitor, MM36, appears to be safe, well-tolerated and provides rapid itch relief when applied …

GBI Research: Global Dermatology Pipeline Will See Shift Tow…

The global dermatology pipeline, which currently comprises 850 products with a disclosed stage of development, is primar…

PuraCap Pharmaceuticals Introduces EpiCeram Quad Pack

PuraCap® Pharmaceutical is introducing the EpiCeram® Controlled Release Skin Barrier Emulsion Quad Pack, which c…

Glenmark Pharmaceuticals Reports Positive Phase 2a Data for …

Glenmark Pharmaceuticals shared positive data from a Phase 2a study of GBR 830, an investigational, anti-OX40 monoclonal…

Valeant’s Newly Minted Ortho Dermatologic Unit Makes Big S…

It’s go big or go home for the newly re-branded Valeant Ortho Dermatologic division. At the 2017 American Acade…

A Growing Biologics Armamentarium for Psoriasis and Atopic D…

There has been a significant amount of research and development in atopic dermatitis and psoriasis in the last couple of…

Get Ready: The Biosimilars Are Here

Marking 10 years of clinical experience using biosimilars, the European Medicines Agency (EMA) and the European Commissi…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.